Hbk Investments L P Gilead Sciences, Inc. Transaction History

Hbk Investments L P

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1.34 Million - $1.52 Million	-22,258 Reduced 80.3%	5,459 $353,000
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $24,642 - $28,079	-435 Reduced 1.55%	27,717 $1.62 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $16,829 - $21,159	-271 Reduced 0.95%	28,152 $1.78 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $17,072 - $19,824	236 Added 0.84%	28,423 $2.19 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.46 Million - $1.87 Million	-23,310 Reduced 45.26%	28,187 $2.11 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $19.1 Million - $21.4 Million	-308,218 Reduced 85.68%	51,497 $3.48 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $6.93 Million - $7.77 Million	110,890 Added 44.57%	359,715 $23.4 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $6.5 Million - $8.49 Million	107,425 Added 75.97%	248,825 $15.6 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $2.45 Million - $2.71 Million	-34,400 Reduced 19.57%	141,400 $10.9 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $11.2 Million - $13.1 Million	-173,209 Reduced 49.63%	175,800 $12.5 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $11.9 Million - $14.5 Million	163,209 Added 87.84%	349,009 $26.3 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $13.2 Million - $15.5 Million	185,800	185,800 $13.3 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.